当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2024-04-02 , DOI: 10.1021/acs.jmedchem.3c02266
Nanxia Zhang 1 , Shige Shen 2 , Mengyu Yang 1 , Sijie He 1 , Chunxiao Liu 2 , Hongmei Li 1 , Tao Lu 1, 3 , Haichun Liu 4 , Qinghua Hu 2 , Weifang Tang 1 , Yadong Chen 1, 3
Affiliation  

NIK plays a crucial role in the noncanonical NF-κB signaling pathway associated with diverse inflammatory and autoimmune diseases. Our study presents compound 54, a novel NIK inhibitor, designed through a structure-based scaffold-hopping approach from the previously identified B022. Compound 54 demonstrates remarkable selectivity and potency against NIK both in vitro and in vivo, effectively suppressing pro-inflammatory cytokines and nitric oxide production. In mouse models, compound 54 protected against LPS-induced systemic sepsis, reducing AST, ALT, and AKP liver injury markers. Additionally, it also attenuates sepsis-induced lung and kidney damage. Mechanistically, compound 54 blocks the noncanonical NF-κB signaling pathway by targeting NIK, preventing p100 to p52 processing. This work reveals a novel class of NIK inhibitors with significant potential for sepsis therapy.

中文翻译:


具有抗炎和保肝作用的新型 NIK 抑制剂用于脓毒症治疗的设计、合成和生物学评价



NIK 在与多种炎症和自身免疫性疾病相关的非经典 NF-κB 信号通路中发挥着至关重要的作用。我们的研究提出了化合物54 ,一种新型 NIK 抑制剂,通过基于结构的支架跳跃方法从先前鉴定的 B022 中设计出来。化合物54在体外和体内均表现出显着的针对 NIK 的选择性和效力,可有效抑制促炎细胞因子和一氧化氮的产生。在小鼠模型中,化合物54可以预防 LPS 诱导的系统性脓毒症,减少 AST、ALT 和 AKP 肝损伤标志物。此外,它还可以减轻败血症引起的肺和肾损伤。从机制上讲,化合物54通过靶向 NIK 来阻断非经典 NF-κB 信号通路,从而阻止 p100 到 p52 的加工。这项工作揭示了一类新型 NIK 抑制剂,具有治疗脓毒症的巨大潜力。
更新日期:2024-04-02
down
wechat
bug